242 related articles for article (PubMed ID: 34121658)
1. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction.
Ramos MIP; Tian L; de Ruiter EJ; Song C; Paucarmayta A; Singh A; Elshof E; Vijver SV; Shaik J; Bosiacki J; Cusumano Z; Jensen C; Willumsen N; Karsdal MA; Liu L; Langermann S; Willems S; Flies D; Meyaard L
Elife; 2021 Jun; 10():. PubMed ID: 34121658
[TBL] [Abstract][Full Text] [Related]
2. Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1.
Vijver SV; Singh A; Mommers-Elshof ETAM; Meeldijk J; Copeland R; Boon L; Langermann S; Flies D; Meyaard L; Ramos MIP
Front Immunol; 2021; 12():733561. PubMed ID: 34691040
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.
Singh A; Mommers-Elshof ETAM; Vijver SV; Jansen JHM; Gonder S; Lebbink RJ; Bihan D; Farndale RW; Boon L; Langermann S; Leusen JHW; Flies D; Meyaard L; Pascoal Ramos MI
Cancer Immunol Immunother; 2024 Jan; 73(1):16. PubMed ID: 38236251
[TBL] [Abstract][Full Text] [Related]
4. Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III.
Lebbink RJ; Raynal N; de Ruiter T; Bihan DG; Farndale RW; Meyaard L
Matrix Biol; 2009 May; 28(4):202-10. PubMed ID: 19345263
[TBL] [Abstract][Full Text] [Related]
5. Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1.
Rygiel TP; Stolte EH; de Ruiter T; van de Weijer ML; Meyaard L
Mol Immunol; 2011 Oct; 49(1-2):402-6. PubMed ID: 21955987
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1.
Xu L; Wang S; Li J; Li J; Li B
Oncoimmunology; 2020 Apr; 9(1):1740477. PubMed ID: 33457088
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the classical and lectin pathway of the complement system by recombinant LAIR-2.
Olde Nordkamp MJ; Boross P; Yildiz C; Jansen JH; Leusen JH; Wouters D; Urbanus RT; Hack CE; Meyaard L
J Innate Immun; 2014; 6(3):284-92. PubMed ID: 24192271
[TBL] [Abstract][Full Text] [Related]
8. The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction.
Lebbink RJ; van den Berg MC; de Ruiter T; Raynal N; van Roon JA; Lenting PJ; Jin B; Meyaard L
J Immunol; 2008 Feb; 180(3):1662-9. PubMed ID: 18209062
[TBL] [Abstract][Full Text] [Related]
9. Molecular Basis of Complement C1q Collagen-Like Region Interaction with the Immunoglobulin-Like Receptor LAIR-1.
Fouët G; Bally I; Chouquet A; Reiser JB; Thielens NM; Gaboriaud C; Rossi V
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066122
[TBL] [Abstract][Full Text] [Related]
10. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1.
Lebbink RJ; de Ruiter T; Adelmeijer J; Brenkman AB; van Helvoort JM; Koch M; Farndale RW; Lisman T; Sonnenberg A; Lenting PJ; Meyaard L
J Exp Med; 2006 Jun; 203(6):1419-25. PubMed ID: 16754721
[TBL] [Abstract][Full Text] [Related]
11. Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1.
Olde Nordkamp MJ; van Roon JA; Douwes M; de Ruiter T; Urbanus RT; Meyaard L
Arthritis Rheum; 2011 Dec; 63(12):3749-57. PubMed ID: 22127695
[TBL] [Abstract][Full Text] [Related]
12. A single residue, arginine 65, is critical for the functional interaction of leukocyte-associated inhibitory receptor-1 with collagens.
Tang X; Narayanan S; Peruzzi G; Apara A; Natarajan K; Margulies DH; Coligan JE; Borrego F
J Immunol; 2009 May; 182(9):5446-52. PubMed ID: 19380792
[TBL] [Abstract][Full Text] [Related]
13. The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR).
Meyaard L; van der Vuurst de Vries AR; de Ruiter T; Lanier LL; Phillips JH; Clevers H
J Exp Med; 2001 Jul; 194(1):107-12. PubMed ID: 11435477
[TBL] [Abstract][Full Text] [Related]
14. Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member.
Lenting PJ; Westerlaken GH; Denis CV; Akkerman JW; Meyaard L
PLoS One; 2010 Aug; 5(8):e12174. PubMed ID: 20730098
[TBL] [Abstract][Full Text] [Related]
15. Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1-mediated tumor eradication.
Horn LA; Chariou PL; Gameiro SR; Qin H; Iida M; Fousek K; Meyer TJ; Cam M; Flies D; Langermann S; Schlom J; Palena C
J Clin Invest; 2022 Apr; 132(8):. PubMed ID: 35230974
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D.
Olde Nordkamp MJ; van Eijk M; Urbanus RT; Bont L; Haagsman HP; Meyaard L
J Leukoc Biol; 2014 Jul; 96(1):105-11. PubMed ID: 24585933
[TBL] [Abstract][Full Text] [Related]
17. A novel antibody-like TCRγδ-Ig fusion protein exhibits antitumor activity against human ovarian carcinoma.
Zheng J; Guo Y; Ji X; Cui L; He W
Cancer Lett; 2013 Dec; 341(2):150-8. PubMed ID: 23920126
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI.
Brondijk TH; de Ruiter T; Ballering J; Wienk H; Lebbink RJ; van Ingen H; Boelens R; Farndale RW; Meyaard L; Huizinga EG
Blood; 2010 Feb; 115(7):1364-73. PubMed ID: 20007810
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of the rat homologue of LAIR-1.
Lebbink RJ; de Ruiter T; Kaptijn GJ; Meyaard L
Immunogenetics; 2005 Jun; 57(5):344-51. PubMed ID: 15902436
[TBL] [Abstract][Full Text] [Related]
20. A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.
Rao B; Gao Y; Zhou Q; Xiao P; Xia S; Ma J; Luo J; Xiao T; Le S; Huang M; Wang J
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1015-23. PubMed ID: 23494077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
